YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non–Small Cell Lung Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

YH25448, an Irreversible EGFR-TKI with Potent Intracranial Activity in EGFR Mutant Non–Small Cell Lung Cancer

Published:2019-01-22 Issue:8 Volume:25 Page:2575-2587
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Yun Jiyeon,Hong Min Hee^ORCID,Kim Seok-Young,Park Chae-Won,Kim Soyoung,Yun Mi Ran,Kang Han Na,Pyo Kyoung-Ho^ORCID,Lee Sung Sook,Koh Jong Sung,Song Ho-Juhn,Kim Dong Kyun,Lee Young-Sung,Oh Se-Woong,Choi Soongyu,Kim Hye Ryun,Cho Byoung Chul

Funder

Ministry of Science, ICT and Future Planning

MSITMOTIEMOHWMOHW

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lazertinib in EGFR-Variant Non–Small Cell Lung Cancer With CNS Failure to Prior EGFR Tyrosine Kinase Inhibitors;JAMA Oncology;2024-08-15

2. Initial AXL and MCL‐1 inhibition contributes to abolishing lazertinib tolerance in EGFR‐mutant lung cancer cells;Cancer Science;2024-07-22

3. Spotlight on Patritumab Deruxtecan (HER3-DXd) from HERTHENA Lung01. Is a Median PFS of 5.5 Months Enough in Light of FLAURA-2 and MARIPOSA?;Lung Cancer: Targets and Therapy;2024-07

4. Amivantamab plus Lazertinib in Previously Untreated EGFR -Mutated Advanced NSCLC;New England Journal of Medicine;2024-06-26

5. Comparative effectiveness of lazertinib in patients with EGFR T790M-positive non-small-cell lung cancer using a real-world external control;Scientific Reports;2024-06-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP